PICOT Question: In patients 30-60 years of age, with acute respiratory distress syndrome caused by COVID 19 (P), does the use of extracorporeal membrane oxygenation (ECMO) improve their outcome in the CVICU (I) compared to non-ECMO interventions (C) affect their survival rate (O) during hospitalization (T).